New drug combo aims to stall prostate cancer spread in High-Risk patients
NCT ID NCT00859781
First seen Apr 10, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tests whether combining an experimental targeted radiation drug (177Lu-J591) with hormone therapy (ketoconazole) can keep prostate cancer from spreading in men whose cancer has returned after initial treatment. About 55 men with high-risk, castration-resistant prostate cancer but no visible metastases will receive the combination. The main goal is to see how many remain free of new cancer spots on scans for 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai
Los Angeles, California, 90048, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
The University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
USC/Norris Comprehensive cancer center
Los Angeles, California, 90089, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.